SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 153 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $195,000 | -3.0% | 17,707 | -4.9% | 0.01% | -25.0% |
Q4 2016 | $201,000 | -28.2% | 18,610 | -31.9% | 0.02% | -11.1% |
Q3 2016 | $280,000 | +56.4% | 27,312 | +99.6% | 0.02% | +80.0% |
Q2 2016 | $179,000 | +5.3% | 13,681 | -21.1% | 0.01% | +25.0% |
Q2 2015 | $170,000 | -8.1% | 17,336 | -17.9% | 0.01% | -20.0% |
Q4 2014 | $185,000 | -24.8% | 21,113 | -40.8% | 0.01% | -33.3% |
Q3 2014 | $246,000 | +43.0% | 35,688 | +9.4% | 0.02% | +50.0% |
Q2 2014 | $172,000 | – | 32,617 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |